SCHEMBL20766478

SCHEMBL20766478

CC(C)Oc1ccc(CN(Cc2ccc(Cl)cc2Cl)C(=O)NC2CCN(C)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766219 0.91 HTR2A (0.63) HTR2A
SCHEMBL20766350 0.88 HTR2A (0.51) HTR2A
SCHEMBL20766399 0.84 HTR2A (0.66) HTR2A
SCHEMBL20766470 0.83 HTR2A (0.65) HTR2A
SCHEMBL20766568 0.83 HTR2A (0.60) HTR2A
SCHEMBL20766341 0.83 HTR2A (0.63) HTR2A
SCHEMBL20766332 0.83 HTR2A (0.63) HTR2A
SCHEMBL20766475 0.82 HTR2A (0.70) HTR2A
SCHEMBL20766683 0.81 HTR2A (0.75) HTR2A
SCHEMBL20766501 0.81 HTR2A (0.62) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672954-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Acadia Pharmaceuticals Inc. (US) 2020-07-01 — — EP disclosed
WO-2019040107-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 — — WO disclosed
Send feedback